In August 2020, we entered into a manufacturing agreement with Lonza for the clinical and commercial supply of the Company’s antibody biopolymer conjugate drug substance
In August 2020, the Company and its wholly owned subsidiary Kodiak Sciences GmbH entered into a manufacturing agreement with Lonza Ltd ("Lonza") for the clinical and commercial supply of the Company'…
Kodiak Sciences Inc. Customers
No clients on recordNo downstream customers found in our database for Kodiak Sciences Inc..
Kodiak Sciences Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
KOD-DEBT-10546
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2018-12-31.
KOD-DEBT
Debt stack $56.0M
90%
Market cache reports total debt of $56.0M.
Kodiak Sciences Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Kodiak Sciences Inc..
Kodiak Sciences Inc. Ownership
Holder
Name
Confidence
Evidence
KOD-OWNER-BAKER-BROS-ADVISORS-LP
BAKER BROS. ADVISORS LP
90%
13F overlay lists BAKER BROS. ADVISORS LP as top holder; 192 tracked holders.
Kodiak Sciences Inc. Extended Supply Chain Network
